Compare municipal bond CEFs: Nuveen Select Tax-Free Income Portfolio looks undervalued, while BlackRock MuniYield Michigan Quality Fund seems pricey. See more.
Why NXP Stock advanced +1.21% Today — RQD Quant Desk Flash
Nuveen Select Tax Free Income Portfolio (NXP) carries a Roarable Rating of C- (Hold) with 59/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 33% of 52W Range • RSI-14 at 55.3 (BULLISH MOMENTUM)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
⚔️ Adversarial Opposing Case: Why the NXP Bull Thesis Could Fail
Even with a 59/100 (C-) score, NXP faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($13.51) or 200D SMA ($14.09) invalidates the momentum regime and cuts Target Base ($13.50) toward Bear Floor ($10.53).
Why NXP Stock advanced +1.21% Today — RQD Quant Desk Flash
Nuveen Select Tax Free Income Portfolio (NXP) advanced +1.21% to $13.44, trading at 33% of its 52-week range ($12.87 – $14.59). Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 33% of its 52-week range ($12.87 – $14.59) with RSI-14 at 55.3 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±3% around $13.44 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 52% gross margin and $17.6M annual free cash flow.
Scheduled RQD Strong Buys & Whale Accumulation Briefing (NXP Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
NXP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on NXP today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for NXP. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NXP)
1. Head-to-Head Financials Peer Comparison (NXP vs. BSTZ, BME, VMO, NDMO)
Industry: Trusts Except Educational Religious and Charitable (32 Tracked Issuers)Across 1096 tracked Financials securities in the Roarable RQD universe, Nuveen Select Tax Free Income Portfolio (NXP) ranks #556 by composite RQD confidence (59/100, grade C-) and #655 by equity capitalization ($629.0M). Within this direct 5-issuer industry benchmark cohort, NXP leads on earnings valuation at N/A trailing P/E, while NXP leads on capital efficiency and profitability with — ROIC and — gross margin. NXP currently leads its immediate peer cohort in composite quantitative strength at 59/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NXP
ACTIVE
Nuveen Select Tax Free Income Portfolio | C- | 59/100 | — | — | — | +1.21% | $629.0M | Benchmark Subject |
| BSTZ BlackRock Science and Technology Term Trust of | D | 51/100 | — | — | — | -0.49% | $627.5M | /bstz-vs-nxp → |
| BME Blackrock Health Sciences Trust | D+ | 53/100 | — | — | — | +1.70% | $623.2M | /bme-vs-nxp → |
| VMO Invesco Municipal Opportunity Trust | C- | 59/100 | — | — | — | +1.12% | $607.0M | /vmo-vs-nxp → |
| NDMO Nuveen Dynamic Municipal Opportunities Fund of | C- | 59/100 | — | — | — | +1.10% | $546.5M | /ndmo-vs-nxp → |
2. NXP Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTNuveen Select Tax Free Income Portfolio (NXP) operates in Trusts Except Educational Religious and Charitable (Financials) with an equity capitalization of $629.0M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
3. NXP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NXP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Nuveen Select Tax Free Income Portfolio (NYSE: NXP) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $13.44 (+1.21% 1D, market cap $629.0M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, NXP ranks #556 in composite RQD confidence.
How does NXP compare to BSTZ and BME in the Financials sector?
Within the Financials sector (Trusts Except Educational Religious and Charitable), NXP carries a Roarable C- (59/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, BSTZ (BlackRock Science and Technology Term Trust of) holds a D grade (51/100 RQD, P/E N/A, ROIC —, cap $627.5M) and BME (Blackrock Health Sciences Trust) posts a D+ grade (53/100 RQD, P/E N/A, ROIC —, cap $623.2M). Among the 5-stock peer group, NXP leads on earnings multiple (N/A) while NXP leads on capital efficiency (— ROIC).
What are the biggest fundamental strengths and SEC risk factors for NXP?
For Nuveen Select Tax Free Income Portfolio (NXP), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #556 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NXP trading relative to its 50-day, 200-day, and 52-week technical levels?
NXP last traded at $13.44 (+1.21% on volume of 289,719 shares), positioning the stock -0.52% below its 50-day simple moving average ($13.51) and -4.61% below its 200-day simple moving average ($14.09). Across its 52-week range of $12.87 to $14.59, NXP sits at the 33.1% percentile with a 14-day RSI of 55.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±3.0% ($13.04 to $13.84).
NXP Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is NXP stock moving today?
Why NXP Stock advanced +1.21% Today — RQD Quant Desk Flash. Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.